M-current modulators alter rat spinal nociceptive transmission: An electrophysiological study in vitro

Neuropharmacology

Volumn 46, Issue 4, 2004, Pages 598-606

  Rivera Arconada, I ^a   Martinez Gomez, J ^a   Lopez Garcia, J A ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Linopirdine; Nociceptive pathways; Retigabine; Spinal reflexes; XE 991

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KCNQ1; RETIGABINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL ROOT; DRUG EFFECT; ELECTROPHYSIOLOGY; MOTONEURON; MOTOR NERVE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; REFLEX; SENSORY NERVE; SPINAL CORD HEMISECTION; STIMULATION;

EID: 1242283867     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.10.016     Document Type: Article

References (28)

1. Alaburda A., Perrier J.F., Hounsgaard J. An M-like outward current regulates the excitability of spinal motoneurones in the adult turtle. Journal of Physiology. 540:2002;875-881.
2. Blackburn-Munro G., Jensen B. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. European Journal of Pharmacology. 460:2003;109-116.
3. Brown B.S., Yu S.P. Modulation and genetic identification of the M channel. Progress in Biophysics and Molecular Biology. 73:2000;135-166.
4. Brown D.A., Adams P.R. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature. 283:1980;673-676.
5. Costa A.M., Brown B.S. Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: mechanisms of action. Neuropharmacology. 36:1997;1747-1753.
6. Dedek K., Kunath B., Kananura C., Reuner U., Jentsch T.J., Steinlein O.K. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proceedings of the National Academy of Science USA. 98:2001;12272-12277.
7. Faber E.S., Chambers J.P., Evans R.H. Selective depression of dorsal root-evoked high threshold synaptic excitation by the selective kappa opioid receptor agonist enadoline in the neonatal rat hemisected spinal cord in vitro. Neuropharmacology. 37:1998;745-750.
8. Hedo G., Lopez-Garcia J.A. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology. 41:2001;862-869.
9. Hedo G., Lopez-Garcia J.A. 5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. British Journal of Pharmacology. 135:2002;935-942.
10. Hedo G., Laird J.M.A., Lopez-Garcia J.A. Time-course of spinal sensitisation following carrageenan-induced inflammation in the young rat: a comparative electrophysiological and behavioural study in vitro and in vivo. Neuroscience. 92:1999;309-318.
11. Jentsch T.J., Schroeder B.C., Kubisch C., Friedrich T., Stein V. Pathophysiology of KCNQ channels: neonatal epilepsy and progressive deafness. Epilepsia. 41:2000;1068-1069.
12. Karchevski, L.A., Burbidge, S.A. and Woolf, C.J., 2001. Localization of KCNQ potassium channels in primary sensory neurones. Society for Neuroscience Abstracts 819.8.
13. Lamas J.A., Selyanko A.A., Brown D.A. Effects of a cognition-enhancer, linopirdine on M-type potassium currents and some other voltage- and ligand-gated membrane currents in rat sympathetic neurones. European Journal of Neuroscience. 9:1997;605-616.
14. Lopez-Garcia J.A., Laird J.M.A. Central antinociceptive effects of meloxicam on rat spinal cord in vitro. Neuroreport. 9:1998;647-651.
15. Main M.J., Cryan J.E., Dupere J.R., Cox B., Clare J.J., Burbidge S.A. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Molecular Pharmacology. 58:2000;253-262.
16. Murase K., Ryu P.D., Randiç M. Substance P augments a persistent slow inward calcium-sensitive current in voltage-clamped spinal dorsal horn neurons of the rat. Brain Research. 365:1986;369-376.
17. Nowak L.M., Macdonald R.L. Muscarine-sensitive voltage-dependent potassium current in cultured murine spinal cord neurons. Neuroscience Letters. 35:1983;85-91.
18. Passmore G.M., Selyanko A.A., Mistry M., Al-Qatari M., Marsh S.J., Matthews E.A., Dickenson A.H., Brown T.A., Burbidge S.A., Main M., Brown D.A. KCNQ/M currents in sensory neurones: significance for pain therapy. Journal of Neuroscience. 23:2003;7227-7236.
19. Rundfeldt C. The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells. European Journal of Pharmacology. 336:1997;243-249.
20. Rundfeldt C., Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neuroscience Letters. 282:2000;73-76.
21. Schnee M.E., Brown B.S. Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons. Journal of Pharmacology Experimental Therapeutics. 286:1998;709-717.
22. Schroder R.L., Jespersen T., Christophersen P., Strobaek D., Jensen B.S., Olesen S.P. KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology. 40:2001;888-898.
23. Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C., Jentsch T.J. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. Journal of Biological Chemistry. 275:2000;24089-24095.
24. Selyanko A.A., Hadley J.K., Wood I.C., Abogadie F.C., Delmas P., Buckley N.J., London B., Brown D.A. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. Journal of Neuroscience. 19:1999;7742-7756.
25. Tatulian L., Delmas P., Abogadie F.C., Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. Journal of Neuroscience. 21:2001;5535-5545.
26. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 282:1998;1890-1893.
27. Wang H.S., Brown B.S., McKinnon D., Cohen I.S. Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE-991. Molecular Pharmacology. 57:2000;1218-1223.
28. Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Molecular Pharmacology. 58:2000;591-600.